XML 22 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jul. 01, 2017
Jul. 02, 2016
Operating Activities:    
Net Income Attributable to Kadant $ 17,047 $ 15,187
Net income attributable to noncontrolling interest 218 243
Net income 17,265 15,430
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 6,531 7,477
Stock-based compensation expense 2,736 2,596
Provision for losses on accounts receivable 84 320
Loss (gain) on the sale of property, plant, and equipment 30 (350)
Other items, net 2,161 289
Contributions to U.S. pension plan (540) (540)
Changes in current assets and liabilities, net of effects of acquisition:    
Accounts receivable (476) 3,699
Unbilled contract costs and fees (2,968) 818
Inventories (6,147) (2,498)
Other current assets (2,652) 459
Accounts payable 3,363 172
Other current liabilities 5,989 (8,663)
Net cash provided by operating activities 25,376 19,209
Investing Activities:    
Acquisition (165) (56,617)
Purchases of property, plant, and equipment (3,435) (1,736)
Proceeds from sale of property, plant, and equipment 50 399
Net cash used in investing activities (3,550) (57,954)
Financing Activities:    
Proceeds from issuance of debt 8,000 46,046
Repayment of debt (11,235) (12,250)
Dividends paid (4,388) (3,894)
Tax withholding payments related to stock-based compensation (2,206) (2,435)
Payment of debt issuance costs (1,147) 0
Payment of contingent consideration 0 (1,091)
Proceeds from issuance of Company common stock 0 1,374
Change in restricted cash 93 724
Other financing activities (215) 0
Net cash (used in) provided by financing activities (11,098) 28,474
Exchange Rate Effect on Cash and Cash Equivalents 3,625 (1,048)
Increase (Decrease) in Cash and Cash Equivalents 14,353 (11,319)
Cash and Cash Equivalents at Beginning of Period 71,487 65,530
Cash and Cash Equivalents at End of Period $ 85,840 $ 54,211